UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cost of Pharmacotherapy in Polish Patients With Rheumatoid Arthritis

Value in health, 2014-11, Vol.17 (7), p.A383-A383

2014

Volltextzugriff (PDF)

Health economics and health technology assessment in Central and Eastern Europe: a dose of reality

The European journal of health economics, 2012-10, Vol.13 (5), p.525-531

2012

Volltextzugriff (PDF)

The Impact of the Polish Human Insulin (Gensulin) on Public Payer’s Expenditure in 2001-2013

Value in health, 2013-11, Vol.16 (7), p.A451-A451

2013

Volltextzugriff (PDF)

Loss of Productivity in Polish Patients with Rheumatoid Arthritis

Value in health, 2013-11, Vol.16 (7), p.A566-A566

2013

Volltextzugriff (PDF)

Burden of Informal Care in Relation to Disease Activity and Disability in Polish Patients with Rheumatoid Arthritis

Value in health, 2013-11, Vol.16 (7), p.A567-A567

2013

Volltextzugriff (PDF)

Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients: Significant Increase of Transportation Needs and Home Visits

Value in health, 2013-11, Vol.16 (7), p.A566-A567

2013

Volltextzugriff (PDF)

PDB23 Budget Impact Analysis of the Reimbursement of Long-Acting Insulin Analogues in Poland

Value in health, 2011, Vol.14 (7), p.A475-A475

2011

Volltextzugriff (PDF)

Health Care Resource Utilization and Costs Associated with Treatment of Polish Acromegalic Patients with Lanreotide Autogel 120 Mg – A Retrospective Observational Cohort Analysis

Value in health, 2013-11, Vol.16 (7), p.A438-A438

2013

Volltextzugriff (PDF)

Assessment of Real-World Usage of Lanreotide (Somatuline Autogel) 120 Mg in Polish Acromegalic Patients – Results from 1 Year Prospective Phase of Lanro-Study

Value in health, 2013-11, Vol.16 (7), p.A438-A438

2013

Volltextzugriff (PDF)

IDF2022-0254 Glutathione S-transferase P1 genetic variants influence the HbA1c level in diabetic patients

Diabetes research and clinical practice, 2023-03, Vol.197, p.110268, Article 110268

2023

Volltextzugriff (PDF)

PCN121 Challenges in Conducting Pharmacoeconomic Analyses in Central and Eastern Europe – Case Study on Breast Cancer

Value in health, 2011, Vol.14 (7), p.A456-A456

2011

Volltextzugriff (PDF)

Economic aspects in medical decision-making

Transplantation proceedings, 2003-05, Vol.35 (3), p.1227-1229

Orlewska, E

2003

Volltextzugriff (PDF)

Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis

Value in health, 2007-09, Vol.10 (5), p.336-347

2007

Volltextzugriff (PDF)

PDB66 PAYING FOR COSTLY PHARMACEUTICALS—REIMBURSEMENT STATUS OF LONG-ACTING INSULIN ANALOGUES IN SELECTED DEVELOPED COUNTRIES

Value in health, 2009, Vol.12 (7), p.A414-A414

2009

Volltextzugriff (PDF)

PMS61 - Cost of Pharmacotherapy in Polish Patients With Rheumatoid Arthritis

Value in health, 2014-11, Vol.17 (7), p.A383-A383

2014

Volltextzugriff (PDF)

Direct Medical Costs of Multiple Sclerosis and Regional Diversity in Access to Disease-Modifying Therapies in Poland Between 2008-2016

Value in health, 2017-10, Vol.20 (9), p.A729

2017

Volltextzugriff (PDF)

PND65 - Direct Medical Costs of Multiple Sclerosis and Regional Diversity in Access to Disease-Modifying Therapies in Poland Between 2008-2016

Value in health, 2017-10, Vol.20 (9), p.A729-A729

2017

Volltextzugriff (PDF)

A prospective study of the financial costs of multiple sclerosis at different stages of the disease

European journal of neurology, 2005-01, Vol.12 (1), p.31-39

2005

Volltextzugriff (PDF)

PDB99 - Real-World Comorbidities, Treatment Pattern and Cost of Patients with Acromegaly in Poland Based on Retrospective Analysis Of Administrative Claims Data

Value in health, 2016-11, Vol.19 (7), p.A682-A683

2016

Volltextzugriff (PDF)

PDB96 - Dispensing Patterns and Cost of Insulins in Poland Between 2012 and 2015

Value in health, 2016-11, Vol.19 (7), p.A682-A682

2016

Volltextzugriff (PDF)

Dispensing Patterns and Cost of Insulins in Poland Between 2012 and 2015

Value in health, 2016-11, Vol.19 (7), p.A682-A682

2016

Volltextzugriff (PDF)

Real-World Comorbidities, Treatment Pattern and Cost of Patients with Acromegaly in Poland Based on Retrospective Analysis Of Administrative Claims Data

Value in health, 2016-11, Vol.19 (7), p.A682-A683

2016

Volltextzugriff (PDF)

PDB116 - The Impact of the Polish Human Insulin (Gensulin) on Public Payer’s Expenditure in 2001-2013

Value in health, 2013-11, Vol.16 (7), p.A451-A451

2013

Volltextzugriff (PDF)

PDB21 - Budget Impact Analysis of Lanreotide Autogel 120 Mg in the Treatment of Acromegaly in Poland

Value in health, 2016-11, Vol.19 (7), p.A668-A668

2016

Volltextzugriff (PDF)

PCN111 - Dose Extension and Costs of Lanreotide Autogel 120 Mg Used in Routine Neuroendocrine Tumors Care In Poland – 2- Years Data From Lanro-Net Study

Value in health, 2016-11, Vol.19 (7), p.A728-A728

2016

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(93)

Sprache

Englisch
(91)
Polnisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cost of Pharmacotherapy in Polish Patients With Rheumatoid Arthritis

Health economics and health technology assessment in Central and Eastern Europe: a dose of reality

The Impact of the Polish Human Insulin (Gensulin) on Public Payer’s Expenditure in 2001-2013

Loss of Productivity in Polish Patients with Rheumatoid Arthritis

Burden of Informal Care in Relation to Disease Activity and Disability in Polish Patients with Rheumatoid Arthritis

Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients: Significant Increase of Transportation Needs and Home Visits

PDB23 Budget Impact Analysis of the Reimbursement of Long-Acting Insulin Analogues in Poland

Health Care Resource Utilization and Costs Associated with Treatment of Polish Acromegalic Patients with Lanreotide Autogel 120 Mg – A Retrospective Observational Cohort Analysis

Assessment of Real-World Usage of Lanreotide (Somatuline Autogel) 120 Mg in Polish Acromegalic Patients – Results from 1 Year Prospective Phase of Lanro-Study

IDF2022-0254 Glutathione S-transferase P1 genetic variants influence the HbA1c level in diabetic patients

PCN121 Challenges in Conducting Pharmacoeconomic Analyses in Central and Eastern Europe – Case Study on Breast Cancer

Economic aspects in medical decision-making

Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis

PDB66 PAYING FOR COSTLY PHARMACEUTICALS—REIMBURSEMENT STATUS OF LONG-ACTING INSULIN ANALOGUES IN SELECTED DEVELOPED COUNTRIES

PMS61 - Cost of Pharmacotherapy in Polish Patients With Rheumatoid Arthritis

Direct Medical Costs of Multiple Sclerosis and Regional Diversity in Access to Disease-Modifying Therapies in Poland Between 2008-2016

PND65 - Direct Medical Costs of Multiple Sclerosis and Regional Diversity in Access to Disease-Modifying Therapies in Poland Between 2008-2016

A prospective study of the financial costs of multiple sclerosis at different stages of the disease

PDB99 - Real-World Comorbidities, Treatment Pattern and Cost of Patients with Acromegaly in Poland Based on Retrospective Analysis Of Administrative Claims Data

PDB96 - Dispensing Patterns and Cost of Insulins in Poland Between 2012 and 2015

Dispensing Patterns and Cost of Insulins in Poland Between 2012 and 2015

Real-World Comorbidities, Treatment Pattern and Cost of Patients with Acromegaly in Poland Based on Retrospective Analysis Of Administrative Claims Data

PDB116 - The Impact of the Polish Human Insulin (Gensulin) on Public Payer’s Expenditure in 2001-2013

PDB21 - Budget Impact Analysis of Lanreotide Autogel 120 Mg in the Treatment of Acromegaly in Poland

PCN111 - Dose Extension and Costs of Lanreotide Autogel 120 Mg Used in Routine Neuroendocrine Tumors Care In Poland – 2- Years Data From Lanro-Net Study

Suchergebnisse filtern